TWiV 992: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Dr. Griffin discusses clearance of longstanding, immune-deficiency-associated, vaccine-derived poliovirus infection following remdesivir therapy for chronic SARS-CoV-2 infection, SARS-CoV-2 exposure in New York City rats, clinical characteristics and outcomes of children with SARS-CoV-2 infection during the Delta and Omicron variant-dominant periods in Korea, exhaled breath aerosol shedding of SARS-CoV-2 variants, outpatient treatment of COVID-19 and the development of long COVID over 10 months, Nirmatrelvir and the risk of post-acute sequelae of COVID-19, assessment of the risk of venous thromboembolism in nonhospitalized patients with COVID-19, and the optimal duration of systemic corticosteroids in COVID-19 treatment. Click arrow to play Download TWiV 992 (19 MB .mp3, 32 min) Subscribe (free): Apple Podcasts , Google Podcasts , RSS , email Become a patron of TWiV! Links for this episode Clearance of vaccine-derived poliovirus following remdesivir therapy for SARS-CoV-2 infection (Frontiers) SARS-CoV-2 exposure in Norway rats from New York City (mBio) Clinical characteristics and outcomes of children with SARS-CoV-2 Infection in Korea (JKMS) Exhaled breath aerosol shedding of SARS-CoV-2 variants (CID) Outpatient treatment of COVID-19 and the development of Long COVID (The Lancet) Nirmatrelvir and the risk of post-acute sequelae of COVID-19 (medRxiv) Risk of venous thromboembolism in nonhospitalized patients with COVID-19 (JAMA) Optimal duration of systemic corticosteroids in COVID-19 treatment (OFID) Contribute to our ASTMH fundraiser at PWB Dr. Griffin's treatment guide ( pdf ) Letters read on TWiV 992 Don't crush Paxlovid ( pdf ) Timestamps by Jolene . Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]